Qi Diagnostics Founder Grover Cheung Serves as Panelist Speaker, Discusses Technological Development and IP Protection at the Intellectual Property Conference
(01 Aug 2024)
On July 25, 2024, Grover Cheung, founder of Qi Diagnostics Limited, was invited to serve as a panelist speaker at the 16th Intellectual Property Conference in Hong Kong. During the roundtable discussion, Mr. Cheung shared insights on the company’s growth, the impact of global economic trends, and strategies for intellectual property protection.
In his remarks, Mr. Cheung reflected on the technological advancements of Qi Diagnostics, particularly the development of their FDA-approved breathalyzer. He discussed how changes in global markets influence technology registration and brand management. As the company expands into global markets, Mr. Cheung emphasized the increasing importance of IP protection, stating that businesses must ensure full compliance in innovation to avoid infringing on existing patents.
These discussions provided attendees with a clearer understanding of how companies in rapidly evolving technological fields can balance innovation with intellectual property protection, driving long-term success.
Qi Diagnostics 創辦人張煒鋒擔任知識產權會議圓桌講者，探討科技發展與知識產權保護
（2024年8月1日）
2024年7月25日，Qi Diagnostics Limited 創辦人 張煒鋒先生 受邀擔任 第16屆香港知識產權會議 的 圓桌會議講者，並就公司發展、全球經濟影響與 知識產權保護 策略進行了分享。
在討論中，張先生回顧了 Qi Diagnostics 的技術進步，特別是其開發的 FDA 認證 KetoAir 氣酮測試機，並分享了全球市場變化如何影響技術註冊和品牌管理。隨著企業在全球市場上的擴展，知識產權的保護變得尤為重要，張先生強調，企業應在創新時嚴格遵循合規，確保技術不侵犯現有的專利。
這些討論讓參會者更清楚了解企業在快速變化的科技領域中，如何平衡創新與知識產權保護，並推動企業的長期成功。